ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,814Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 1269

$635K Total Retail Price of All Prescriptions

Rank: 74 out of 1269

579 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 579 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 579 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 9,073 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 567 497 1 2
SIMVASTATIN 421 332 2 3
LISINOPRIL 369 293 3 1
TRAMADOL HCL 329 286 4 16
FUROSEMIDE 326 302 5 5
PRAVASTATIN SODIUM 285 257 6 11
METOPROLOL TARTRATE 270 235 7 6
OMEPRAZOLE 262 230 8 8
HYDROCHLOROTHIAZIDE 227 187 9 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 200 165 10 33
LEVOTHYROXINE SODIUM 193 176 11 4
ATORVASTATIN CALCIUM 182 164 12 7
METFORMIN HCL 175 126 13 9
CARVEDILOL 161 136 14 29
POTASSIUM CHLORIDE 150 139 15 26
NIFEDIPINE ER 146 137 16 65
IBUPROFEN 140 69 17 73
LOSARTAN-HYDROCHLOROTHIAZIDE 139 116 18 59
RANITIDINE HCL 136 87 19 27
GABAPENTIN 134 103 20 17
HYDROCODONE-ACETAMINOPHEN 129 116 S3 21 20
TAMSULOSIN HCL 118 102 22 31
CLONIDINE HCL 116 51 23 51
COLCRYS 112 112 24 150
TRIAMTERENE-HCTZ 110 103 25 69
AMLODIPINE BESYLATE-BENAZEPRIL 107 103 26 81
DONEPEZIL HCL 106 106 27 22
OXYCODONE-ACETAMINOPHEN 94 63 S2 28 44
CLOPIDOGREL 88 85 29 32
ATENOLOL 85 83 30 14
ZOLPIDEM TARTRATE 85 64 30 19
SYMBICORT 85 70 30 173
GLIPIZIDE 84 60 33 37
WARFARIN SODIUM 84 83 33 12
GLYBURIDE-METFORMIN HCL 83 75 R 35 172
PLAVIX 76 73 36 47
ADVAIR DISKUS 73 57 37 46
LACTULOSE 72 68 38 67
TRAMADOL HCL-ACETAMINOPHEN 69 59 39 164
METOPROLOL SUCCINATE 68 66 40 13
ALLOPURINOL 68 66 40 49
CHLORTHALIDONE 65 60 42 179
GLYBURIDE 63 57 R 43 94
ALENDRONATE SODIUM 61 59 44 28
OXYBUTYNIN CHLORIDE 58 53 45 128
FLUTICASONE PROPIONATE 54 46 46 40
LOSARTAN POTASSIUM 53 52 47 15
OXYCODONE HCL 52 27 S2 48 34
INSULIN SYRINGE 52 40 48 87
DIVALPROEX SODIUM 52 47 48 54
NIFEDICAL XL 51 48 51 138
HALOPERIDOL 51 39 51 133
PROAIR HFA 51 34 51 61
VENTOLIN HFA 51 48 51 100
DIOVAN HCT 51 43 51 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.